FGF2 and chronic obstructive pulmonary disease: Therefore, in the next section, we will review the immunomodulatory function of FGF2 in both inflammatory cells and airway structural cells (summarized in Figure 2), and discuss the possibility of targeting FGF2 so as to inhibit airway chronic inflammation in asthma and COPD.